Brendan Smith - 16 Aug 2022 Form 4 Insider Report for CRISPR Therapeutics AG (CRSP)

Role
Chief Financial Officer
Signature
/s/ Elizabeth Ryland Waldinger, attorney-in-fact
Issuer symbol
CRSP
Transactions as of
16 Aug 2022
Net transactions value
$0
Form type
4
Filing time
18 Aug 2022, 17:39:09 UTC
Previous filing
22 Feb 2022
Next filing
12 Oct 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRSP Restricted Stock Units Award $0 +10,000 $0.000000 10,000 16 Aug 2022 Common Shares 10,000 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.
F2 The restricted stock units shall vest in full on February 16, 2025, subject to continued service to the Company or any of its subsidiaries.

Remarks:

Exhibit 24 - Power of Attorney